AlphaFold predicted structure
AMT · P48728

Mean pLDDT
93.7/ 100
Very high
403 residues
Confidence breakdown
- Very high(≥ 90)92%
- Confident(70–90)1%
- Low(50–70)1%
- Very low(< 50)7%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
aminomethyltransferase
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
glycine encephalopathy
glycine encephalopathy 1
hereditary disease
Neurodevelopmental delay
atypical glycine encephalopathy
infantile glycine encephalopathy
neonatal glycine encephalopathy
inflammatory bowel disease
Abnormality of the skeletal system
substance-related disorder
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Aminomethyltransferase, mitochondrial
The glycine cleavage system catalyzes the degradation of glycine
AMT · P48728

Mean pLDDT
93.7/ 100
Very high
403 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0